Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Beavis PA"'
Autor:
Sutton VR; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Watt SV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Akhlaghi H; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Cipolla DC; Insmed Incorporated, Bridgewater, NJ, United States., Chen KJ; Insmed Incorporated, Bridgewater, NJ, United States., LaSala D; Insmed Incorporated, Bridgewater, NJ, United States., McDonald PP; Insmed Incorporated, Bridgewater, NJ, United States., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Hodel AW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Noori T; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Voskoboinik I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2024 Jul 03; Vol. 15, pp. 1396710. Date of Electronic Publication: 2024 Jul 03 (Print Publication: 2024).
Autor:
Van Der Byl W; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia., Nüssing S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Peters TJ; Garvan Institute of Medical Research, Sydney, NSW, Australia; University of New South Wales Sydney, Sydney, NSW, Australia., Ahn A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Li H; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Ledergor G; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., David E; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Koh AS; Department of Pathology, University of Chicago, Chicago, IL, USA., Wagle MV; Garvan Institute of Medical Research, Sydney, NSW, Australia; John Curtin School of Medical Research, ANU, Canberra, ACT, Australia., Deguit CDT; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., de Menezes MN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Travers A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sampurno S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Li R; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA., Kallies A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Jungmann R; Faculty of Physics and Center for Nanoscience, Ludwig Maximilian University, Munich, Germany; Max Planck Institute of Biochemistry, Martinsried, Germany., Bastings MMC; Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Interfaculty Bioengineering Institute, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Belz GT; The Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Goel S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Crabtree GR; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA., Chang HY; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA., Amit I; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Goodnow CC; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia., Luciani F; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia. Electronic address: luciani@unsw.edu.au., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; John Curtin School of Medical Research, ANU, Canberra, ACT, Australia. Electronic address: ian.parish@petermac.org.
Publikováno v:
Immunity [Immunity] 2024 Jun 11; Vol. 57 (6), pp. 1324-1344.e8. Date of Electronic Publication: 2024 May 21.
Autor:
Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Scheffler CM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Lee JN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Yap KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Saw NYL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Dunbar PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hoang TX; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., de Menezes MN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kim JS; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Leung PSK; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia., So J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Deguit C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Zhu J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kats LM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Scott AM; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.; Faculty of Medicine, The University of Melbourne, Parkville, Victoria, Australia., Solomon BJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Clinical Haematology and Centre of Excellence for Cellular Immunotherapies, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Oliaro J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Quinn KM; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. junyun.lai@unimelb.edu.au.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. junyun.lai@unimelb.edu.au., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. paul.beavis@petermac.org., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. phil.darcy@petermac.org.; Clinical Haematology and Centre of Excellence for Cellular Immunotherapies, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Department of Immunology, Monash University, Clayton, Victoria, Australia. phil.darcy@petermac.org.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8010), pp. 201-210. Date of Electronic Publication: 2024 Apr 10.
Autor:
House IG, Derrick EB, Sek K, Chen AXY, Li J, Lai J, Todd KL, Munoz I, Michie J, Chan CW, Huang YK, Chan JD, Petley EV, Tong J, Nguyen D, Engel S, Savas P, Hogg SJ, Vervoort SJ, Kearney CJ, Burr ML, Lam EYN, Gilan O, Bedoui S, Johnstone RW, Dawson MA, Loi S, Darcy PK, Beavis PA
Publikováno v:
Cell reports [Cell Rep] 2024 Feb 27; Vol. 43 (2), pp. 113793. Date of Electronic Publication: 2024 Feb 05.
Autor:
Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. Kirsten.Todd@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. Kirsten.Todd@petermac.org., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Newman DM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Koay HF; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, VIC, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Hoang TX; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Lee JN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Kim JS; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., N de Menezes M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Scheffler CM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Yap KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Dunbar PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Haugen B; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Johnstone RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Department of Immunology, Monash University, Clayton, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. paul.beavis@petermac.org.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 01; Vol. 14 (1), pp. 6990. Date of Electronic Publication: 2023 Nov 01.
Autor:
House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: imran.house@petermac.org., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Michie J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Engel S; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Institute of Experimental Immunology, University of Bonn, Bonn, Germany., Savas P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Hogg SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Vervoort SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Kearney CJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Burr ML; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; Department of Anatomical Pathology, The Royal Melbourne Hospital, Melbourne, VIC 3050, Australia., Lam EYN; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Gilan O; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Bedoui S; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Institute of Experimental Immunology, University of Bonn, Bonn, Germany., Johnstone RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Dawson MA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3052, Australia; Centre for Cancer Research, The University of Melbourne, Melbourne, VIC 3000, Australia., Loi S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Immunology, Monash University, Clayton, VIC, Australia. Electronic address: phil.darcy@petermac.org., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: paul.beavis@petermac.org.
Publikováno v:
Cell reports [Cell Rep] 2023 Aug 29; Vol. 42 (8), pp. 113014. Date of Electronic Publication: 2023 Aug 21.
Autor:
Meyran D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Université de Paris, Inserm, U976 HIPI Unit, Institut de Recherche Saint-Louis, Paris F-75010, France.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Zhu JJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Butler J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Tantalo D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., MacDonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Nguyen TN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Wang M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Thio N; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., D'Souza C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Qin VM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Slaney C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Harrison A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Petrone P; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Thia K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Giuffrida L; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia., Scott AM; Tumor Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Terry RL; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 1466, Australia., Tran B; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Desai J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Prince HM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Solomon B; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Ekert PG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 1466, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW 1466, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW 2031, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC 3052, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne 3010, Australia.
Publikováno v:
Science translational medicine [Sci Transl Med] 2023 Apr 05; Vol. 15 (690), pp. eabk1900. Date of Electronic Publication: 2023 Apr 05.
Autor:
Richardson K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Keam SP; Tumor Suppression and Cancer Sex Disparity Lab, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Zhu JJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Meyran D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., D'Souza C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Macdonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Campbell K; Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111., Robbins M; Translational Medicine, Bristol-Myers Squibb, Cambridge, MA, USA, (current: io904 LLC)., Bezman NA; Oncology Discovery Research, Bristol-Myers Squibb, Redwood City, CA., Todd K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Quach H; Department of Haematology, St Vincent's Hospital, Melbourne, Australia; Faculty of Medicine, The University of Melbourne., Ritchie DS; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Harrison SJ; Faculty of Medicine, The University of Melbourne, Australia; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Prince HM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Faculty of Medicine, The University of Melbourne, Australia; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Jenkins MR; Faculty of Medicine, The University of Melbourne, Australia; Immunology Division, Walter and Eliza Hall Institute, Melbourne, Australia; Institute for Molecular Science, La Trobe University, Bundoora., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne. Paul.neeson@petermac.org.
Publikováno v:
Haematologica [Haematologica] 2023 Jan 01; Vol. 108 (1), pp. 83-97. Date of Electronic Publication: 2023 Jan 01.
Autor:
Chan KL; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia., Gomez J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia., Cardinez C; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia., Kumari N; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Sparbier CE; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lam EYN; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Yeung MM; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Garciaz S; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, 13009 Marseille, France., Kuzich JA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Ong DM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia., Brown FC; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia., Chan YC; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Vassiliadis D; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Wainwright EN; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Motazedian A; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Gillespie A; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Fennell KA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lai J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., House IG; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Macpherson L; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Ang CS; Melbourne Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Centre for Cancer Research, The University of Melbourne, Parkville, VIC 3000, Australia., Beavis PA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia., Burr ML; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, ACT 2606, Australia. Electronic address: marian.burr@anu.edu.au., Dawson MA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Centre for Cancer Research, The University of Melbourne, Parkville, VIC 3000, Australia. Electronic address: mark.dawson@petermac.org.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Oct 10; Vol. 40 (10), pp. 1190-1206.e9. Date of Electronic Publication: 2022 Sep 29.
Autor:
Souza-Fonseca-Guimaraes F; University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia., Rossi GR; University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia., Dagley LF; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Advanced Technology & Biology, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Foroutan M; Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., McCulloch TR; University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia., Yousef J; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Advanced Technology & Biology, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Park HY; Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Gunter JH; Australian Prostate Cancer Research Centre - QLD, Centre for Genomics and Personalised Health, School of Biomedical Science, Queensland University of Technology, Brisbane, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia., Lin CY; University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia., Hediyeh-Zadeh S; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Australian Prostate Cancer Research Centre - QLD, Centre for Genomics and Personalised Health, School of Biomedical Science, Queensland University of Technology, Brisbane, Australia., Camilleri T; Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Davis MJ; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Division of Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Huntington ND; Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Sep 01; Vol. 10 (9), pp. 1047-1054.